Compare COLM & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COLM | CDNA |
|---|---|---|
| Founded | 1938 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 1997 | 2007 |
| Metric | COLM | CDNA |
|---|---|---|
| Price | $59.92 | $67.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $69.83 | $61.67 |
| AVG Volume (30 Days) | 603.5K | ★ 1.4M |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.17 | ★ 2.13 |
| Revenue | ★ $3,042,478,000.00 | $48,324,000.00 |
| Revenue This Year | $1.78 | $30.36 |
| Revenue Next Year | $3.12 | $6.23 |
| P/E Ratio | $51.51 | ★ $30.02 |
| Revenue Growth | N/A | ★ 18.93 |
| 52 Week Low | $47.48 | $14.03 |
| 52 Week High | $69.06 | $72.51 |
| Indicator | COLM | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 61.36 |
| Support Level | $55.35 | $61.19 |
| Resistance Level | $65.02 | $72.51 |
| Average True Range (ATR) | 1.42 | 4.05 |
| MACD | 0.40 | -0.42 |
| Stochastic Oscillator | 68.29 | 48.59 |
Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.